We are live on ! Find out more
LP

Longaeva Partners Portfolio holdings

AUM $4.58B
1-Year Est. Return 43.91%
This Fund
S&P 500
This Quarter Est. Return
-3.4%
1 Year Est. Return
+43.91%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.7B
AUM Growth
+$1.51B
Cap. Flow
+$1.41B
Cap. Flow %
52.36%
Top 10 Hldgs %
35.87%
Holding
269
New
150
Increased
33
Reduced
19
Closed
65

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$80.3M
2
BSX icon
Boston Scientific
BSX
+$76.6M
3
KEY icon
KeyCorp
KEY
+$62.3M
4
GS icon
Goldman Sachs
GS
+$60.3M
5
MMED
MiniMed Group Inc
MMED
+$52.4M

Top Sells

Rank Stock Value
1
CAI
Caris Life Sciences
CAI
+$40.7M
2
BDX icon
Becton Dickinson
BDX
+$25.5M
3
TPG icon
TPG
TPG
+$23.9M
4
NVO
Novo Nordisk
NVO
+$22.6M
5
EW icon
Edwards Lifesciences
EW
+$22.1M

Sector Composition

Rank Sector Weight
1 Financials 31.18%
2 Miscellaneous 23.14%
3 Healthcare 16.78%
4 Technology 12.09%
5 Industrials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QXO
251
QXO Inc
QXO
$14B
– –
-93,545
Closed -$1.8M
WAY
252
Waystar Holding Corp
WAY
$5.03B
– –
-86,642
Closed -$2.84M
TEM
253
Tempus AI
TEM
$11.6B
– –
-12,772
Closed -$754K
BKV
254
BKV Corp
BKV
$2.65B
– –
-21,364
Closed -$580K
SARO
255
StandardAero Inc
SARO
$8.28B
– –
-15,518
Closed -$445K
XYZ
256
Block Inc
XYZ
$50.2B
– –
-104,842
Closed -$6.82M
SAIL
257
SailPoint Inc
SAIL
$11.2B
– –
-24
Closed -$486
KMTS
258
Kestra Medical Technologies
KMTS
$1.5B
– –
-16,565
Closed -$439K
KKR.PRD
259
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
$2.47B
– –
-125,000
Closed -$6.48M
CAI
260
Caris Life Sciences
CAI
$7.24B
– –
-1,509,745
Closed -$40.7M
SLDE
261
Slide Insurance Holdings
SLDE
$2.74B
– –
-63,027
Closed -$1.23M
NIQ
262
NIQ Global Intelligence PLC
NIQ
$5.66B
– –
-497,489
Closed -$8.2M
KLAR
263
Klarna Group
KLAR
$5.37B
– –
-115,000
Closed -$3.32M
FIGR
264
Figure Technology Solutions
FIGR
$8.09B
– –
-27,414
Closed -$1.12M
STUB
265
StubHub Holdings
STUB
$2.5B
– –
-1,450,047
Closed -$15.1M
XZO
266
Exzeo Group
XZO
$1.52B
– –
-38,000
Closed -$922K
CBC
267
Central Bancompany Inc
CBC
$7.81B
– –
-5,295
Closed -$128K
WLTH
268
Wealthfront Corp
WLTH
$1.38B
– –
-175,000
Closed -$2.38M
ANDG
269
Andersen Group
ANDG
$6.3B
– –
-69,028
Closed -$1.79M
7 8 9 10
11

Similar funds

CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
MR
Munich Reinsurance Munich $4.57B AUM 28.39% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.59B AUM 9.32% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
AF
Avanza Fonder Stockholm, Sweden $4.59B AUM 41.03% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

Longaeva Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Longaeva Partners held 269 positions worth $2.7B, up 127% from $1.19B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Longaeva Partners deployed $1.41B of net new capital in Q1 2026, opening 150 new positions and adding to 33 existing holdings. Its largest new stake was Bank of America: 1,555,661 shares worth $75.8M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Annexon, an estimated $14M trimmed.

  • Longaeva Partners's largest Q1 2026 buy was Bank of America: 1,555,661 shares worth $75.8M.
  • Longaeva Partners added most to PNC Financial Services in Q1 2026, an estimated $48M increase.
  • Longaeva Partners's biggest Q1 2026 reduction was Annexon, cutting an estimated $14M.
  • Longaeva Partners fully exited Caris Life Sciences in Q1 2026, selling an estimated $40.7M.
  • Longaeva Partners's ten largest holdings make up 36% of its $2.7B portfolio in Q1 2026.
  • Longaeva Partners opened 150 new positions and closed 65 in Q1 2026.
  • Longaeva Partners's portfolio value rose 127% quarter-over-quarter to $2.7B.

Based on Longaeva Partners's 13F filing for Q1 2026, filed 15 May 2026.